title: Severe T-mediated bone marrow aplasia in a patient with splenic lymphoma with villous lymphocytes (SLVL) previously treated with fludarabine regimen.
authors.affiliation: Division of Hematology, Ospedale S. Gennaro, Via S. Gennaro dei Poveri 25, 80134 Napoli, Italy. stefrocco@virgilio.it
authors.forename: Stefano
authors.initials: S
authors.lastname: Rocco
authors.forename: Salvatore
authors.initials: S
authors.lastname: Improta
authors.forename: Marco
authors.initials: M
authors.lastname: Sagristani
authors.forename: Ada A
authors.initials: AA
authors.lastname: Quirino
authors.forename: Giampiero
authors.initials: G
authors.lastname: Nitrato Izzo
authors.forename: Silvia
authors.initials: S
authors.lastname: Russolillo
authors.forename: Maria Teresa
authors.initials: MT
authors.lastname: Polistina
authors.forename: Lucia
authors.initials: L
authors.lastname: Mastrullo
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects*; D001855:Bone Marrow Diseases / Q000139:chemically induced*; D006801:Humans; D016393:Lymphoma, B-Cell / Q000188:drug therapy*; D013160:Splenic Neoplasms / Q000188:drug therapy*; D013601:T-Lymphocytes / Q000187:drug effects / Q000473:pathology*; D014740:Vidarabine / Q000009:adverse effects / Q000031:analogs & derivatives*
chemical_list: D000970:Antineoplastic Agents; D014740:Vidarabine; C024352:fludarabine